Marketing-authorisation holder · Canada
10445517 Canada Inc / North Pharmaceuticals / Dac Pharmaceuticals
14 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
14 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| AZITHROMYCIN600 mg · Tablet | Azithromycin | Canada | Authorised | |
| AZITHROMYCIN250 mg · Tablet | Azithromycin | Canada | Marketed | 2025 |
| CIPROFLOXACIN250 mg · Tablet | Ciprofloxacin | Canada | Authorised | |
| CIPROFLOXACIN500 mg · Tablet | Ciprofloxacin | Canada | Marketed | 2025 |
| CIPROFLOXACIN750 mg · Tablet | Ciprofloxacin | Canada | Authorised | |
| PANTOPRAZOLE40 mg · Tablet (Delayed-Release) | Pantoprazole | Canada | Marketed | 2024 |
| PANTOPRAZOLE20 mg · Tablet (Delayed-Release) | Pantoprazole | Canada | Authorised | |
| ROSUVASTATIN20 mg · Tablet | Rosuvastatin | Canada | Marketed | 2026 |
| ROSUVASTATIN10 mg · Tablet | Rosuvastatin | Canada | Marketed | 2026 |
| ROSUVASTATIN5 mg · Tablet | Rosuvastatin | Canada | Marketed | 2026 |
| ROSUVASTATIN40 mg · Tablet | Rosuvastatin | Canada | Marketed | 2026 |
| SILDENAFIL CITRATE50 mg · Tablet | Sildenafil | Canada | Authorised | |
| SILDENAFIL CITRATE100 mg · Tablet | Sildenafil | Canada | Authorised | |
| SILDENAFIL CITRATE25 mg · Tablet | Sildenafil | Canada | Authorised |